Evidence map›Paper›PMID 26107679›Full record

Observational studyMedicine2015

Unintentional Discontinuation of Chronic Medications for Seniors in Nursing Homes: Evaluation of a National Medication Reconciliation Accreditation Requirement Using a Population-Based Cohort Study.

Nathan M Stall, Hadas D Fischer, C Fangyun Wu, Arlene S Bierman, Stacey Brener, Susan Bronskill, Edward Etchells, Olavo Fernandes, Davina Lau, Muhammad M Mamdani and 3 more

Erratum issuedAbstract readObservational Study
In one paragraph

Observational study in Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

13 authors.

Nathan M StallFrom the Department of Medicine (NMS, EE, CMB), University of Toronto; Institute for Clinical and Evaluative Sciences (HDF, ASB, S Bronskill, MMM, PR, DRU, CFW, CMB); Keenan Research Centre (ASB, MMM), Li Ka Shing Knowledge Institute, St Michael's Hospital; Institute of Health Policy, Management and Evaluation (ASB, S Bronskill, EE, PR, DRU, CMB); Lawrence S. Bloomberg Faculty of Nursing (ASB), University of Toronto; Health Quality Ontario (S Brener); Department of Pharmacy (OF), University Health Network; Leslie Dan Faculty of Pharmacy (OF, MMM), University of Toronto; Division of General Internal Medicine (DL, CMB), Mount Sinai Hospital; Women's College Research Institute (PR), Women's College Hospital; and Department of Surgery (DRU), University of Toronto, Toronto, Canada.
Hadas D Fischer
C Fangyun Wu
Arlene S Bierman
Stacey Brener
Susan Bronskill
Edward Etchells
Olavo Fernandes
Davina Lau
Muhammad M Mamdani
Paula Rochon
David R Urbach
Chaim M Bell

Funding

Canadian Institutes of Health Research 92630
6 · The paper itself

Abstract

Transitions of care leave patients vulnerable to the unintentional discontinuation of medications with proven efficacy for treating chronic diseases. Older adults residing in nursing homes may be especially susceptible to this preventable adverse event. The effect of large-scale policy changes on improving this practice is unknown.The objective of this study was to analyze the effect of a national medication reconciliation accreditation requirement for nursing homes on rates of unintentional medication discontinuation after hospital discharge.It was a population-based retrospective cohort study that used linked administrative records between 2003 and 2012 of all hospitalizations in Ontario, Canada. We identified nursing home residents aged ≥66 years who had continuous use of ≥1 of the 3 selected medications for chronic disease: levothyroxine, HMG-CoA reductase inhibitors (statins), and proton pump inhibitors (PPIs).In 2008 medication reconciliation became a required practice for accreditation of Canadian nursing homes.The main outcome measures included the proportion of patients who restarted the medication of interest after hospital discharge at 7 days. We also performed a time series analysis to examine the impact of the accreditation requirement on rates of unintentional medication discontinuation.The study included 113,088 adults aged ≥66 years who were nursing home residents, had an acute hospitalization, and were discharged alive to the same nursing home. Overall rates of discontinuation at 7-days after hospital discharge were highest in 2003-2004 for all nursing homes: 23.9% for thyroxine, 26.4% for statins, and 23.9% for PPIs. In most of the cases, these overall rates decreased annually and were lowest in 2011-2012: 4.0% for thyroxine, 10.6% for statins, and 8.3% for PPIs. The time series analysis found that nursing home accreditation did not significantly lower medication discontinuation rates for any of the 3 drug groups.From 2003 to 2012, there were marked improvements in rates of unintentional medication discontinuation among hospitalized older adults who were admitted from and discharged to nursing homes. This change was not directly associated with the new medication reconciliation accreditation requirement, but the overall improvements observed may have been reflective of multiple processes and not 1 individual intervention.

Indexed as

AccreditationAgedAged, 80 and overChronic DiseaseFemaleHumansMaleMedication ReconciliationNursing HomesRetrospective Studies

Identifiers

PMID26107679
PMCPMC4504593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.